In this study, we present the first evidence that NID1 promotes the migration, invasion and chemoresistance of ovarian cancer cells via EMT and its molecular mechanism involves the activation of ERK/MAPK signaling. The gene discussed is NID1; the disease is ovarian carcinoma.